NRIX
Nurix Therapeutics Inc
22.20$
-2.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -257.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +11.0% | +3.5% | +5.2% | +1.3% | +3.8% | -4.1% | +23.5% | -1.9% | -7.4% | -18.5% | +2.0% | – | |
| – | -5.0% | -2.5% | +13.1% | -1.0% | -2.8% | +2.5% | +19.1% | -5.9% | -7.0% | +3.5% | +21.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -119.0% | – | – | – | -3,224.5% | – | – | -109.4% | – | -200.0% | – | |
| – | +5.1% | +11.6% | -32.8% | +21.2% | -10.3% | +65.6% | -23.2% | +1.3% | +89.3% | -79.6% | +85.3% | – | |
| – | -163.1% | – | -469.1% | -83.7% | +559.9% | – | +180.0% | -29.4% | -99.3% | -35,887.9% | – | – | |
| – | – | – | – | – | – | – | – | +78.0% | – | – | – | – | |
| – | -99.6% | +23,100.0% | +14,539.9% | -80.7% | +338.1% | -99.3% | -99.6% | +19,150.0% | +20,333.6% | -91.5% | -99.7% | – | |
| – | – | -139.1% | – | -126.5% | – | -411.2% | – | -169.0% | – | -204.3% | – | – | |
| – | – | -286.0% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.